Other names: Ozempic, Wegovy
Categories: Prescription Medication
Description:
Semaglutide is a GLP-1 receptor agonist that has become a leading option for type 2 diabetes due to its powerful effects on both blood sugar control and weight loss. Given as a once-weekly injection, it offers convenience along with strong cardiovascular protection, making it especially valuable for patients with obesity or high cardiovascular risk. Its significant benefits have made it a preferred early addition to modern diabetes treatment regimens.
Treatment For:
AI generated Summary: Based on the single expert review provided, Semaglutide appears to be a highly effective treatment for Type 2 Diabetes. Its once-weekly dosing lowers blood sugar, promotes weight loss, and reduces cardiovascular risk, making it a preferred option particularly for patients with obesity or heart disease risk factors. The reviewer rates its efficacy as 4 out of 5.
Semaglutide is a once-weekly GLP-1 receptor agonist that lowers blood sugar, promotes weight loss, and reduces cardiovascular risk in type 2 diabetes. Its strong efficacy and convenience make it a preferred option, especially for patients with obesity or heart disease risk.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
